Robert A. Leadbetter

2.3k total citations
22 papers, 1.5k citations indexed

About

Robert A. Leadbetter is a scholar working on Psychiatry and Mental health, Pulmonary and Respiratory Medicine and Molecular Biology. According to data from OpenAlex, Robert A. Leadbetter has authored 22 papers receiving a total of 1.5k indexed citations (citations by other indexed papers that have themselves been cited), including 13 papers in Psychiatry and Mental health, 9 papers in Pulmonary and Respiratory Medicine and 6 papers in Molecular Biology. Recurrent topics in Robert A. Leadbetter's work include Electrolyte and hormonal disorders (8 papers), Bipolar Disorder and Treatment (6 papers) and Ion Transport and Channel Regulation (5 papers). Robert A. Leadbetter is often cited by papers focused on Electrolyte and hormonal disorders (8 papers), Bipolar Disorder and Treatment (6 papers) and Ion Transport and Channel Regulation (5 papers). Robert A. Leadbetter collaborates with scholars based in United States, Netherlands and United Kingdom. Robert A. Leadbetter's co-authors include Alan Metz, Brenda D. Jamerson, Joseph R. Calabrese, Rafe Donahue, Harry A. Croft, Carolyn Watson, Charles L. Bowden, Robin White, James F. Pradko and Anita H. Clayton and has published in prestigious journals such as American Journal of Psychiatry, Biological Psychiatry and Epilepsia.

In The Last Decade

Robert A. Leadbetter

22 papers receiving 1.4k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Robert A. Leadbetter United States 15 984 378 294 228 186 22 1.5k
Michael D. Lesem United States 16 943 1.0× 216 0.6× 704 2.4× 207 0.9× 195 1.0× 24 2.0k
Po W. Wang United States 29 1.2k 1.2× 185 0.5× 431 1.5× 148 0.6× 162 0.9× 88 2.0k
W. W. Fleischhacker Austria 19 861 0.9× 160 0.4× 211 0.7× 103 0.5× 141 0.8× 53 1.5k
Gwen L. Zornberg United States 15 692 0.7× 404 1.1× 238 0.8× 104 0.5× 202 1.1× 23 1.9k
Jayendra K. Patel United States 16 2.0k 2.0× 433 1.1× 515 1.8× 154 0.7× 84 0.5× 22 2.4k
S.H. Hamilton United States 18 2.4k 2.4× 725 1.9× 483 1.6× 273 1.2× 156 0.8× 41 3.0k
Steven J. Romano United States 21 798 0.8× 239 0.6× 490 1.7× 155 0.7× 69 0.4× 32 1.6k
Subramoniam Madhusoodanan United States 21 779 0.8× 220 0.6× 175 0.6× 123 0.5× 97 0.5× 62 1.5k
Heike Hunger Germany 13 1.5k 1.5× 273 0.7× 282 1.0× 233 1.0× 98 0.5× 14 1.9k
J. Peuskens Belgium 11 1.2k 1.2× 274 0.7× 436 1.5× 93 0.4× 83 0.4× 19 1.9k

Countries citing papers authored by Robert A. Leadbetter

Since Specialization
Citations

This map shows the geographic impact of Robert A. Leadbetter's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Robert A. Leadbetter with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Robert A. Leadbetter more than expected).

Fields of papers citing papers by Robert A. Leadbetter

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Robert A. Leadbetter. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Robert A. Leadbetter. The network helps show where Robert A. Leadbetter may publish in the future.

Co-authorship network of co-authors of Robert A. Leadbetter

This figure shows the co-authorship network connecting the top 25 collaborators of Robert A. Leadbetter. A scholar is included among the top collaborators of Robert A. Leadbetter based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Robert A. Leadbetter. Robert A. Leadbetter is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Fava, Maurizio, et al.. (2023). Distinguishing and treating demoralization syndrome in cancer: A review. General Hospital Psychiatry. 85. 185–190. 15 indexed citations
2.
Csernansky, John G., Robert A. Leadbetter, Anne C. Andorn, et al.. (2021). PANSS Individual Item and Marder Dimension Analyses From a Pivotal Trial of RBP-7000 (Monthly Extended-Release Risperidone) in Schizophrenia Patients. The Journal of Clinical Psychiatry. 82(5). 8 indexed citations
3.
Tomson, Torbjörn, Lawrence J. Hirsch, Daniel Friedman, et al.. (2012). Sudden unexpected death in epilepsy in lamotrigine randomized‐controlled trials. Epilepsia. 54(1). 135–140. 44 indexed citations
4.
Calabrese, Joseph R., et al.. (2008). Lamotrigine in the acute treatment of bipolar depression: results of five double‐blind, placebo‐controlled clinical trials. Bipolar Disorders. 10(2). 323–333. 167 indexed citations
5.
Bowden, Charles L., et al.. (2004). Safety and Tolerability of Lamotrigine for Bipolar Disorder. Drug Safety. 27(3). 173–184. 76 indexed citations
6.
Goodwin, Guy M., Charles L. Bowden, Joseph R. Calabrese, et al.. (2004). A Pooled Analysis of 2 Placebo-Controlled 18-Month Trials of Lamotrigine and Lithium Maintenance in Bipolar I Disorder. The Journal of Clinical Psychiatry. 65(3). 432–441. 267 indexed citations
7.
Appelbaum, Paul S., et al.. (2003). Competence to Consent to Research Among Long-Stay Inpatients With Chronic Schizophrenia. Psychiatric Services. 54(9). 1247–1252. 70 indexed citations
8.
Jain, Adesh K., Roy A. Kaplan, Kishore M. Gadde, et al.. (2002). Bupropion SR vs. Placebo for Weight Loss in Obese Patients with Depressive Symptoms. Obesity Research. 10(10). 1049–1056. 145 indexed citations
9.
Croft, Harry A., Trisha L. Houser, Brenda D. Jamerson, et al.. (2002). Effect on body weight of bupropion sustained-release in patients with major depression treated for 52 weeks. Clinical Therapeutics. 24(4). 662–672. 47 indexed citations
10.
Johnston, Andrew J., John A. Ascher, Robert A. Leadbetter, et al.. (2002). Pharmacokinetic Optimisation of Sustained-Release Bupropion for Smoking Cessation. Drugs. 62(Supplement 2). 11–24. 66 indexed citations
11.
Clayton, Anita H., James F. Pradko, Harry A. Croft, et al.. (2002). Prevalence of Sexual Dysfunction Among Newer Antidepressants. The Journal of Clinical Psychiatry. 63(4). 357–366. 399 indexed citations
12.
Leadbetter, Robert A., et al.. (2002). Mood-Stabilizing Properties of Lamotrigine: A Review of Data from Controlled Clinical Trials. Psychiatric Annals. 32(12). 766–777. 5 indexed citations
13.
Leadbetter, Robert A., Michael S. Shutty, Ahmed Elkashef, et al.. (1999). MRI Changes During Water Loading in Patients With Polydipsia and Intermittent Hyponatremia. American Journal of Psychiatry. 156(6). 958–960. 15 indexed citations
14.
Leadbetter, Robert A., et al.. (1997). Polydipsia-Hyponatraemia Syndrome. CNS Drugs. 7(2). 121–138. 14 indexed citations
15.
Shutty, Michael S., et al.. (1997). Diurnal urine volume estimates in schizophrenic patients with polydipsia during water-loaded versus nonloaded states. Biological Psychiatry. 41(3). 374–376. 2 indexed citations
16.
Trugman, Joel M., et al.. (1994). Treatment of severe axial tardive dystonia with clozapine: Case report and hypothesis. Movement Disorders. 9(4). 441–446. 75 indexed citations
18.
Shutty, Michael S., et al.. (1992). Behavioral intervention to reduce water intake in the syndrome of psychosis, intermittent hyponatremia, and polydipsia. Journal of Behavior Therapy and Experimental Psychiatry. 23(1). 51–57. 14 indexed citations
19.
Shutty, Michael S., et al.. (1992). Development and validation of a behavioral observation measure for the syndrome of psychosis, intermittent hyponatremia, and polydipsia. Journal of Behavior Therapy and Experimental Psychiatry. 23(3). 213–219. 7 indexed citations
20.
Vieweg, Victor, et al.. (1991). Cigarette Use and Hyponatremia in Schizophrenic Patients. American Journal of Psychiatry. 148(5). 688–b. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026